» Articles » PMID: 11013246

Tau Filament Formation in Transgenic Mice Expressing P301L Tau

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Oct 3
PMID 11013246
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the microtubule-associated protein tau, including P301L, are genetically coupled to hereditary frontotemporal dementia with parkinsonism linked to chromosome 17. To determine whether P301L is associated with fibril formation in mice, we expressed the longest human tau isoform, human tau40, with this mutation in transgenic mice by using the neuron-specific mouse Thy1.2 promoter. We obtained mice with high expression of human P301L tau in cortical and hippocampal neurons. Accumulated tau was hyperphosphorylated and translocated from axonal to somatodendritic compartments and was accompanied by astrocytosis and neuronal apoptosis indicated by terminal deoxynucleotidyl transferase-mediated biotinylated dUTP nick end-labeling staining. Moreover, P301L tau formed abnormal filaments. Electron microscopy of sarcosyl-insoluble protein extracts established that the filaments had a straight or twisted structure of variable length and were approximately 15 nm wide. Immunoelcecton microscopy showed that the tau filaments were phosphorylated at the TG3, AT100, AT8, and AD199 epitopes in vivo. In cortex, brain stem, and spinal cord, neurofibrillary tangles were also identified by thioflavin-S fluorescent microscopy and Gallyas silver stains. Together, our results show that expression of the P301L mutation in mice causes neuronal lesions that are similar to those seen in human tauopathies.

Citing Articles

pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates.

Walkiewicz G, Ronisz A, Ospitalieri S, Tsaka G, Tome S, Vandenberghe R Acta Neuropathol Commun. 2024; 12(1):194.

PMID: 39707519 PMC: 11662635. DOI: 10.1186/s40478-024-01907-8.


A novel tauopathy model mimicking molecular and spatial aspects of human tau pathology.

Yanai R, Mitani T, Susaki E, Minamihisamatsu T, Shimojo M, Saito Y Brain Commun. 2024; 6(5):fcae326.

PMID: 39420962 PMC: 11483584. DOI: 10.1093/braincomms/fcae326.


Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration.

Majumder M, Dutta D Cells. 2024; 13(13.

PMID: 38994964 PMC: 11240328. DOI: 10.3390/cells13131112.


Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice.

Kabbani M, Kohler C, Zempel H Neural Regen Res. 2024; 20(8):2348-2360.

PMID: 38934386 PMC: 11759014. DOI: 10.4103/NRR.NRR-D-23-01742.


Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.

Collins H, Greenfield S Int J Mol Sci. 2024; 25(11).

PMID: 38892408 PMC: 11172947. DOI: 10.3390/ijms25116222.